Apollo Hospitals Reports Q1 Net Profit Surge of 38% YoY to Rs 610 Crore, with Revenue Growth of 21%.

Apollo Hospitals Enterprise has demonstrated robust financial performance for Q1FY27, with consolidated net profit jumping 38.4% year-on-year to Rs 610 crore, compared to Rs 441 crore in the same quarter the previous year. This significant profit increase has been underpinned by a 20.6% rise in revenue from operations, reaching Rs 7,044 crore, against Rs 5,842 crore in Q1FY26. Furthermore, the company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) showed a commendable increase of 28.2%, amounting to Rs 1,092 crore, which has led to an enhanced EBITDA margin of 15.5%, up from 14.6% a year prior.

Operationally, Apollo’s Healthcare Services sector exhibited substantial growth, with a 22% year-on-year revenue increase, resulting in an EBITDA of Rs 862 crore. Additionally, the Apollo Health and Lifestyle division recorded a 15% revenue growth to Rs 499 crore. The overall revenue increase can be attributed to heightened volumes across specialty services and a greater share of high-complexity clinical work, indicating a successful execution of strategic initiatives to enhance service offerings.

The company is actively expanding its capacity to meet rising demand, having launched a new 180-bed hospital in Sarjapur, Bengaluru. Future expansion plans include the commissioning of its Gurugram facility slated for Q3FY27 and a commitment to add approximately 1,200 beds across various locations. Notably, Apollo aims to augment its overall capacity by more than 5,000 beds over the next five years, reflecting a strategic vision aimed at bolstering operational capabilities in response to growing healthcare needs.

In terms of international operations, Apollo’s International Patient Services division reported a 26% revenue growth, reaffirming its status as a preferred healthcare destination for foreign patients. Founder and Chairman Prathap C. Reddy emphasized that this strong quarter sets a positive trajectory for FY27, highlighting the strength of Apollo’s integrated healthcare model. Furthermore, the planned transfer of Apollo HealthCo’s consumer products business to a wholly owned subsidiary suggests a strategic move to streamline operations and focus on core healthcare services, pending shareholder approval.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova team.)